Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorA.M.I. Agency for Medical Innovations GmbH

About this trial

The purpose of this clinical investigation is to collect clinical data about the ProGYNious Mesh based on a prospective clinical investigation. The primary objective is to verify the treatment outcome and success of the ProGYNious mesh implant in pelvic organ prolapse repair. The secondary objective is to confirm the safety, risks, complications and quality of life of ProGYNious as an implant for pelvic organ prolapse repair.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject is a candidate for surgical repair of pelvic organ prolapse by ProGYNious implant according to the indication of the product under evaluation

Symptomatic pelvic organ prolapse with POP-Q >= 2

Age >18 years and ≤ 80years

Subject is willing and able to cooperate with follow-up examinations

Disqualifiers

previous or concurrent cancer which may affect the successful treament with laparoscopic mesh

known or suspected hypersensitivity to ProGYNious mesh or a component of ProGYNious mesh (Polypropylene)

known severe osteoporosis

pregnancy, suspected pregnancy and breastfeeding

Trial design

Design model

Single group

Treatments tested in this trial

  • Surgical mesh for pelvic organ prolapse repair (ProGYNious)

    Device

    Implantation of a pelvic floor mesh implant for laparoscopic sacrocolpopexy

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Laparoscopic surgery with a synthetic mesh implant (ProGYNious)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Objective cure rate for pelvic organ prolapse

Objective cure rate during follow-up defined by: 1. Anatomic cure by POP-Q \<= 1 (Pelvic Organ Prolapse Quantification System) 2. Absence of bulge symptoms 3. No additional pelvic organ prolapse treatment necessary

Time frame
3 months and 12 months post-operative

Secondary outcomes

1

Complications and adverse events during follow-up

Peri- and post-operative complications, mesh erosion / mesh extrusion (analyzed according to the ICS/IUGA Complication Classification), de novo stress urinary incontinence, de novo urge urinary incontinence

Time frame
3 months and 12 months post-operative
2

Objective outcome (POP-Q)

Intra-individual comparison of the POP-Q (Pelvic Organ Prolapse Quantification System) locations and antomical markers (pre-operative vs. post-operative). The Pelvic Organ Prolapse Quantification (POP-Q) system is an objective, standardized, site-specific system used by clinicians to assess, describe, and stage pelvic support in women. It uses 6 anatomical points measured in centimeters relative to the hymen to diagnose the severity of prolapse.

Time frame
3 months and 12 months post-operative
3

Quality of Life (QoL) and sexual function

Analysis of the improvement in quality of life (QoL) and sexual function with the German Pelvic Floor Questionnaire (GPFQ, Deutscher Beckenbodenfragebogen). The GPFQ does contain the domains bladder function, bowel function, prolapse and sexual symptoms. In each domain a total of 10 points may be reached. The maximum symptom score for the entire questionnaire are 40 points.

Time frame
3 months and 12 months post-operative
4

Subjective success

Subjective success described by Patients Global Impression of Improvement (PGI-I). Patient Global Impression of Improvement (PGI-I) score four years after incontinence surgery. The Patient Global Impression of Improvement (PGI-I) is a global index that may be used to rate the response of a condition to a therapy (transition scale). It is a simple, direct, easy to use scale that is intuitively understandable to clinicians: * Very much better * Much better * A little better * No change * A little worse * Much worse * Very much worse

Time frame
3 months and 12 months post-operative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: